<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:NCBITaxon="http://purl.obolibrary.org/obo/NCBITaxon#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:ncbitaxon="http://purl.obolibrary.org/obo/ncbitaxon#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Molecular Microbiology (2013) 90(2), 443&#8211;455 &#9632;                                                             doi:10.1111/mmi.12376 <br />                                                                                          First published online 9 September 2013 <br />  <br />  <br />  <br /> <span id='am-32' about='obo:NCBITaxon_5690' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_33682 obo:NCBITaxon_5654 obo:NCBITaxon_2759 obo:NCBITaxon_5653'><span id='am-33'  ></span><span id='am-34' property="rdfs:label" content="Trypanosoma" datatype="xsd:string"></span><span id='am-35' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-36' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>Trypanosoma</span> brucei (UMP synthase null mutants) are <br /> avirulent mice, recover virulence prolonged <br /> culture vitro retaining pyrimidine auxotrophy <br />  <br /> Han B. Ong, Natasha Sienkiewicz,&#8224; Susan Wyllie,                   Introduction <br /> Stephen Patterson Alan H. Fairlamb* <br /> Divisional Biological Chemistry Drug Discovery,            The neglected tropical disease human African trypanoso- <br /> College Life Sciences, University Dundee, Dundee            miasis (HAT) caused <span id='am-67' about='obo:NCBITaxon_subspecies' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-68' property="rdfs:label" content="subspecies" datatype="xsd:string"></span><span id='am-69' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>subspecies</span> proto- <br /> DD1 5EH, UK.                                                      zoan parasite <span id='am-37' about='obo:NCBITaxon_5691' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_39700 obo:NCBITaxon_33682 obo:NCBITaxon_5654 obo:NCBITaxon_5690 obo:NCBITaxon_2759 obo:NCBITaxon_5653'><span id='am-38' property="oboInOwl:hasRelatedSynonym" content="Trypanosoma brucei subgroup" datatype="xsd:string"></span><span id='am-39' property="rdfs:label" content="Trypanosoma brucei" datatype="xsd:string"></span><span id='am-40'  ></span><span id='am-41' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-42' property="oboInOwl:hasRelatedSynonym" content="Trypanosoma (Trypanozoon) brucei" datatype="xsd:string"></span><span id='am-43' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Trypanosoma brucei</span> (T. b. gambiense and <br />                                                                   T. b. rhodesiense). Current drugs used treatment <br />                                                                   disease far ideal plagued many <br /> Summary                                                           disadvantages, high cost, toxic side-effects, drug <br />                                                                   resistance lack oral bioavailability (Fairlamb, 2003; <br /> African trypanosomes capable novo <br />                                                                   Stuart et al., 2008). In <span id='am-59' about='obo:NCBITaxon_order' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-60' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-61' property="rdfs:label" content="order" datatype="xsd:string"></span>order</span> develop suitable more <br /> synthesis salvage pyrimidines. The two <br />                                                                   effective drugs, enzymes essential metabolic pathways <br /> steps novo synthesis catalysed UMP <br />                                                                   assessed potential drug targets. One such <br /> synthase (UMPS) &#8211; bifunctional enzyme comprising <br />                                                                   pathway examined pyrimidine metabolism in <br /> orotate phosphoribosyl transferase (OPRT) oro- <br />                                                                   T. brucei. <br /> tidine monophosphate decarboxylase (OMPDC). To <br />                                                                      Pyrimidine (deoxy)-nucleotides essential <br /> investigate essentiality pyrimidine biosynthe- <br />                                                                   precursors synthesis RNA DNA, as <br /> sis Trypanosoma brucei, generated umps <br />                                                                   CDP UDP conjugates biosynthesis glycocon- <br /> double knockout (DKO) line gene replacement. <br />                                                                   jugates, complex lipids and, organisms, isopre- <br /> The DKO unable grow pyrimidine-depleted <br />                                                                   noids (via non-mevalonate pathway), in <br /> medium vitro, unless supplemented uracil, <br />                                                                   secondary metabolism plants xenobiotic <br /> uridine, deoxyuridine UMP. DKO parasites were <br />                                                                   metabolism animals. Most cells, including trypano- <br /> completely resistant 5-fluoroorotate hypersen- <br />                                                                   somes (Hammond Gutteridge, 1984), obtain their <br /> sitive 5-fluorouracil, consistent loss UMPS, <br />                                                                   pyrimidine requirement novo biosynthe- <br /> but remained sensitive pyrazofurin indicating that, <br />                                                                   sis salvage pathways (Fig. 1). In novo biosyn- <br /> unlike mammalian cells, primary target pyrazo- <br />                                                                   thetic pathway, precursor bicarbonate converted <br /> furin OMPDC. The null mutant unable to <br />                                                                   carbamoyl phosphate carbamoyl phosphate syn- <br /> infect mice indicating salvage host pyrimi- <br />                                                                   thase aspartate carbamoyltransferase cycliza- <br /> dines insufficient support growth. However, fol- <br />                                                                   tion form dihydroorotate dihydroorotase. These <br /> lowing prolonged culture vitro, parasites regained <br />                                                                   enzymes fused humans (CAD protein) whereas <br /> virulence mice despite retaining pyrimidine aux- <br />                                                                   separate trypanosomatids. Dihydroorotate is <br /> otrophy. Unlike wild-type, pyrimidine aux- <br />                                                                   converted dihydroorotate dehydrogenase (DHOD) to <br /> otrophs secreted substantial quantities orotate, <br />                                                                   form orotic acid. The human enzyme (Enzyme Commis- <br /> significantly higher virulent DKO line. We pro- <br />                                                                   sion number 1.3.5.2), located mitochondrial <br /> pose responsible recovery of <br />                                                                   membrane transfers electrons ubiquinone, the <br /> virulence mice, host metabolism converting <br />                                                                   target immunomodulatory drug, leflunomide, used <br /> orotate uridine, bypassing loss of <br />                                                                   treat rheumatoid arthritis (Herrmann et al., 2000). In <br /> UMPS parasite. <br />                                                                   contrast, trypanosomal enzyme (EC 1.3.98.1) is <br />                                                                   located cytosol uses fumarate <span id='am-62' about='obo:NCBITaxon_1118549' typeof='owl:Thing obo:NCBITaxon_33213 obo:NCBITaxon_8936 obo:NCBITaxon_1329799 obo:NCBITaxon_1 obo:NCBITaxon_32523 obo:NCBITaxon_131567 obo:NCBITaxon_32524 obo:NCBITaxon_436489 obo:NCBITaxon_117570 obo:NCBITaxon_89593 obo:NCBITaxon_7742 obo:NCBITaxon_117571 obo:NCBITaxon_57387 obo:NCBITaxon_33154 obo:NCBITaxon_8782 obo:NCBITaxon_436486 obo:NCBITaxon_1338369 obo:NCBITaxon_8287 obo:NCBITaxon_2759 obo:NCBITaxon_8492 obo:NCBITaxon_6072 obo:NCBITaxon_33511 obo:NCBITaxon_33208 obo:NCBITaxon_7711 obo:NCBITaxon_8825 obo:NCBITaxon_7776 obo:NCBITaxon_436492 obo:NCBITaxon_32561 obo:NCBITaxon_8457 obo:NCBITaxon_436491'><span id='am-63' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-64' property="rdfs:label" content="Electron" datatype="xsd:string"></span><span id='am-65' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-66'  ></span>electron</span> <br />                                                                   acceptor (Arakaki et al., 2008). RNAi knockdown of <br /> Accepted 22 August, 2013. *For correspondence. E-mail             DHOD T. brucei reported retard growth in <br /> a.h.fairlamb@dundee.ac.uk; Tel. (+44) 1382 385155; Fax (+44)      vitro pyrimidine-depleted medium DHOD-deficient <br /> 1382 385542. &#8224;Present address: Integrated Magnetic Systems Ltd, <br /> Prospect Business Centre, Gemini Crescent, Dundee Technology      trypanosomes hypersensitive 5-fluorouracil <br /> Park, Dundee DD2 1TY, UK.                                         (Arakaki et al., 2008). A umps null been <br />  <br /> &#169; 2013 The Authors. Molecular Microbiology published John Wiley &amp; Sons Ltd. <br /> <span id='am-49' about='obo:NCBITaxon_169495' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_169440 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_7147 obo:NCBITaxon_43733 obo:NCBITaxon_33154 obo:NCBITaxon_43738 obo:NCBITaxon_480117 obo:NCBITaxon_33317 obo:NCBITaxon_169449 obo:NCBITaxon_480118 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_43750 obo:NCBITaxon_33208 obo:NCBITaxon_85512 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_7203 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33392 obo:NCBITaxon_169455 obo:NCBITaxon_50557 obo:NCBITaxon_43741'><span id='am-50' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-51'  ></span><span id='am-52' property="rdfs:label" content="This" datatype="xsd:string"></span><span id='am-53' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>This</span> open access article terms Creative Commons Attribution License, permits use, distribution and <br /> reproduction medium, provided original work properly cited. <br />  444 H. B. Ong et al. &#9632; <br />  <br />                                                                                                              uridine                  uracil <br />  <br />  <br />  <br />  <br />                                                                                           O <br />                                                                                                    R                                                            O <br />                                                                                      HN <br />                                                                                                                             UPase                          HN <br />                                                                                                                                                                     R <br />                                                                                   O       N            uridine                                   uracil <br />                                                                                                                                                           O     N <br />                                                                        HO                                                                                       H <br />                                                                                      O                                     Pi   Ribose-1-P <br />  <br />  <br />                                                                               OH         OH <br />                                                                                                                                           PRPP <br />                                                                                                                                                           UPRT <br />  <br />  <br />                                                                                                    O                                                  O <br />                                                                                                          R                                                 R <br />                                                                                               HN                                                 HN <br />                                      O <br />                                                                                           O        N     COO-                                  O      N <br />                                               R          OPRT                                                 OMPDC                                                     RNA, DNA &amp; <br />    HCO3- + Gln                  HN <br />                                                                         2-O PO                                                   2-O PO <br />    + ATP + Asp <br />                                                                            3              O                                         3          O                          sugar <br />                                O     N        COO- <br />                                      H <br />                                                          PRPP                                                          CO2                                              nucleotides <br />                                                                                          OH    OH                                           OH     OH <br />  <br />                                                                                orotidine                                                 uridine <br />                                orotate <br />                                                                              monophosphate                                            monophosphate <br />  <br />                                                               O                                                             O <br />                                                                   NH2                                                           NH2 <br />                                                          HN                                                           HN <br />                                                          N                                                             N        OH <br />                                                                   OH <br />                                                                                  ? <br />                                          HO                                                        2-O PO <br />                                                      O                                                3           O <br />  <br />                                                                             ATP          ADP <br />                                                   OH     OH                                                      OH    OH <br />  <br />  <br />                                               pyrazofurin                                                pyrazofurin <br />                                                                                                         monophosphate <br />  <br />  <br /> Fig. 1. Key steps pyrimidine novo biosynthesis salvage pathways T. brucei. Orotate converted uridine monophosphate via <br /> the bifunctional UMP synthase (OPRT OMPDC). Uracil salvaged uridine phosphorylase (UPase) uridine uridine <br /> phosphoribosyl transferase (UPRT). Both pyrimidines transported specific pyrimidine transporter (U3). In T. cruzi pyrazofurin is <br /> proposed phosphorylated adenosine kinase order inhibit OMPDC (Hammond Gutteridge, 1983). In structures R = H for <br /> the metabolites R = F antimetabolites 5-fluoroorotate 5-fluorouracil. <br />  <br />  <br /> produced positive&#8211;negative selection                                                   enzyme annotated uridine monophosphate syn- <br /> genetic manipulation T. brucei (Scahill et al., 2008).                                              thase (UMPS, EC 2.4.2.10). OPRT OMPDC in <br /> Although normal growth phenotype observed                                                 T. brucei comprise single bifunctional enzyme <br /> authors ascribed sufficient pyrimidines pro-                                              (Tb927.5.3810). However, order fusion protein <br /> vided serum components standard medium,                                                  reversed (i.e. OMPDC-OPRT) and, unusually, UMPS in <br /> this study open criticism Herpes simplex virus                                          T. brucei localized unique organelle, glyco- <br /> thymidine kinase, broad substrate specificity                                                some, cytosol (Hammond Gutteridge, <br /> for deoxypyrimidines, used gene replacement                                                    1984). <br /> (Balzarini et al., 2002). However, virulence vivo                                              Genetic chemically induced pyrimidine starvation <br /> assessed studies. In final steps                                          results thymineless death prokaryotes eukary- <br /> novo biosynthesis, orotate converted orotidine                                             otes (Ahmad et al., 1998). These effects reversed <br /> 5&#8242;-monophosphate (OMP) uridine 5&#8242;-monopho-                                                        supplementation pyrimidines taken <br /> sphate (UMP) enzymes orotidine phosphoribosyl                                                   growth medium salvage pathways. To <br /> transferase (OPRT, EC 2.4.4.10) orotidine 5&#8242;-                                                      date, pyrimidine transport systems (U1, U2 C1) <br /> monophosphate decarboxylase (OMPDC, EC 4.1.1.23)                                                       identified biochemically insect stage of <br /> respectively. OPRT OMPDC separate mono-                                                        T. brucei (Gudin et al., 2006). However, additional <br /> functional enzymes bacteria certain para-                                                  uracil transporter (U3) identified mamma- <br /> sites, humans form single bifunctional                                               lian stage distinct procyclic transporters <br />  <br />                &#169; 2013 The Authors. Molecular Microbiology published John Wiley &amp; Sons Ltd., Molecular Microbiology, 90, 443&#8211;455 <br />                                                                                                       T. brucei UMP synthase drug target 445 <br />  <br />                                                                                   SacI       3.3 kb              SacI <br />  <br />                 kbp     WT     SKOHYG SKOPAC DKO                      UMPS                          UMPS <br />  <br />  <br />                 4                                                                 SacI     2.8 kb         SacI <br />  <br />                 3                                             &#916;UMPS::HYG                            HYG <br />  <br />  <br />                                                                                    SacI   2.4 kb     SacI <br />                 2 <br />                                                                  &#916;UMPS::PAC                    PAC <br />  <br />  <br /> Fig. 2. Genotypic analysis WT, SKO DKO cell lines. Southern blot analysis SacI-digested genomic DNA (&#8764;5 &#956;g) diploid <br /> wild-type trypanosomes (WT), &#916;UMPS::HYG (SKOHYG); &#916;UMPS:PAC (SKOPAC); &#916;UMPS::HYG/&#916;UMPS::PAC (DKO) using probe against <br /> the 5&#8242;-UTR UMPS. A schematic representation OMPDC locus gene replacements shown right blot. <br />  <br />  <br /> (Ali et al., 2013a). This sole transporter expressed          DKO) generated replacing the <br /> in bloodstream forms U3 high-affinity uracil             second allelic copy PAC cloned line SKOHYG <br /> and lower affinity uridine deoxyuridine (Ali            resistant hygromycin puromycin. The geno- <br /> et al., 2013a). Trypanosomes lack uridine kinase activity            type respective stage confirmed Southern <br /> (Hammond Gutteridge, 1982), uridine con-             blot analysis genomic DNA (Fig. 2). SacI restric- <br /> verted uracil uridine phosphorylase uracil             tion endonuclease cuts genomic DNA 1950-bp <br /> subsequently converted UMP uracil phosphori-                  upstream 13-bp downstream UMPS open <br /> bosyltransferase. The 5-fluoropyrimidine analogues                reading frame yielding &#8764; 3.3 kbp fragment be <br /> orotate, uridine uracil (R = F Fig. 1) follow        detected Southern analysis using probe the <br /> pathway (Ali et al., 2013a). Plasma pyrimidine levels            5&#8242;-UTR. In DKO cells, replaced fragments of <br /> tightly regulated low micromolar range              &#8764; 2.8 kbp (HYG) &#8764; 2.4 kbp (PAC), indicating suc- <br /> thought novo biosynthesis required meet            cessful integration HYG PAC genes loss of <br /> high demand pyrimidines rapidly dividing cells.               UMPS (Fig. 2). These cells cultured hygro- <br /> Thus, reasoned non-essentiality novo               mycin/puromycin-free media confirmation the <br /> synthesis vitro apply vivo.                          validity umps null mutant. <br />    Using classical gene replacement nutritional <br /> rescue strategy, evaluated essentiality               Growth analyses umps null bloodstream <br /> UMPS, novo pyrimidine biosynthesis,                   T. brucei mutants <br /> T. brucei vitro vivo. Inhibitors target pyrimi- <br /> dine metabolism tested antitrypanoso-            Our ability generate propagate DKO cell line in <br /> mal activity, including pyrazofurin, pro-drug              HMI9T agrees previous genome-wide study by <br /> metabolized 5&#8242;-monophosphate-derivative,             RNAi UMPS non-essential vitro (Alsford et al., <br /> a potent inhibitor mammalian OMPDC (Cadman et al.,                2011). Thus, pyrimidines present normal culture <br /> 1978) (Fig. 1). Our findings indicate pyrimidine bio-           medium provided 10% fetal calf serum (FCS) 10% <br /> synthesis important growth parasites             Serum Plus (a proprietary supplement containing 20% <br /> and prolonged culture non-physiological medium               FCS unknown components) serving as <br /> can significantly alter virulence phenotype vivo pos-         metabolic bypass loss novo biosynthesis. <br /> sibly excreting orotate metabolized uridine         Moreover, high concentration thymidine HMI9T <br /> by host.                                                         sparing effect pyrimidine requirements or <br />                                                                      theoretically thymidine metabolized UMP as <br />                                                                      <span id='am-21' about='obo:NCBITaxon_5140' typeof='obo:NCBITaxon_222544 owl:Thing obo:NCBITaxon_5139 obo:NCBITaxon_1 obo:NCBITaxon_5148 obo:NCBITaxon_131567 obo:NCBITaxon_4751 obo:NCBITaxon_147550 obo:NCBITaxon_715989 obo:NCBITaxon_33154 obo:NCBITaxon_451864 obo:NCBITaxon_147538 obo:NCBITaxon_4890 obo:NCBITaxon_716546 obo:NCBITaxon_716545 obo:NCBITaxon_2759'><span id='am-22' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-23' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-24' property="rdfs:label" content="Neurospora" datatype="xsd:string"></span><span id='am-25'  ></span>Neurospora</span> <span id='am-1' about='obo:NCBITaxon_688987' typeof='owl:Thing obo:NCBITaxon_37581 obo:NCBITaxon_37567 obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_85604 obo:NCBITaxon_116123 obo:NCBITaxon_33154 obo:NCBITaxon_33317 obo:NCBITaxon_41191 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_57992 obo:NCBITaxon_33208 obo:NCBITaxon_197562 obo:NCBITaxon_41196 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_41197 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_7088 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33392 obo:NCBITaxon_50557'><span id='am-2' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-3'  ></span><span id='am-4' property="rdfs:label" content="Crassa" datatype="xsd:string"></span><span id='am-5' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>crassa</span> (Shaffer et al., 1975). In <br /> Results                                                              HMI9T medium DKO cells grew marginally slower com- <br />                                                                      pared WT doubling times 6.2 5.5 h respec- <br /> Generation umps null mutants <br />                                                                      tively (Fig. 3, Table S1). Parasites HMI9T medium <br /> The essentiality UMPS T. brucei examined                passaged trypanosome basal medium plus <br /> classical sequential gene replacement, using transfection            10% FCS (TBMFCS; essentially HMI9 Serum Plus or <br /> with drug-resistance genes selectable markers. The                thymidine) determine cells require Serum Plus for <br /> first copy UMPS replaced HYG <span id='am-54' about='obo:NCBITaxon_9605' typeof='owl:Thing obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_9526 obo:NCBITaxon_9604 obo:NCBITaxon_32523 obo:NCBITaxon_131567 obo:NCBITaxon_32524 obo:NCBITaxon_117570 obo:NCBITaxon_32525 obo:NCBITaxon_89593 obo:NCBITaxon_7742 obo:NCBITaxon_117571 obo:NCBITaxon_33154 obo:NCBITaxon_1437010 obo:NCBITaxon_1338369 obo:NCBITaxon_40674 obo:NCBITaxon_8287 obo:NCBITaxon_2759 obo:NCBITaxon_314146 obo:NCBITaxon_6072 obo:NCBITaxon_33511 obo:NCBITaxon_33208 obo:NCBITaxon_7711 obo:NCBITaxon_314293 obo:NCBITaxon_314295 obo:NCBITaxon_376913 obo:NCBITaxon_7776 obo:NCBITaxon_9347 obo:NCBITaxon_207598 obo:NCBITaxon_9443'><span id='am-55' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-56' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-57'  ></span><span id='am-58' property="rdfs:label" content="Homo" datatype="xsd:string"></span>homo</span>-                    growth. In medium, doubling times slightly <br /> logous recombination generate single knockout                   increased 6.1 h (WT) 7.2 h (DKO) compared with <br /> (SKOHYG) line resistant hygromycin. A double knockout             cells grown HMI9T (Fig. 3, Table S1). Next, FCS in <br /> null mutant (&#916;UMPS::HYG/&#916;UMPS::PAC, referred here-                   TBMFCS replaced 10% dialysed FCS completely <br />  <br /> &#169; 2013 The Authors. Molecular Microbiology published John Wiley &amp; Sons Ltd., Molecular Microbiology, 90, 443&#8211;455 <br />  446 H. B. Ong et al. &#9632; <br />  <br />  <br />  <br />  <br />                   Cumulative growth, cells ml -1 <br />  <br />  <br />  <br />  <br />                                                                                                                       Cumulative growth, cells ml -1 <br />                                                    10 21                                                                                               10 21 <br />                                                                    A                                                                                               B <br />                                                    10 18                                                                                               10 18 <br />  <br />                                                    10 15                                                                                               10 15 <br />  <br />                                                    10 12                                                                                               10 12 <br />  <br />                                                    10 9                                                                                                10 9 <br />  <br />                                                    10 6                                                                                                10 6 <br />  <br />                                                    10 3                                                                                                10 3 <br />                                                            0       2       4      6    8    10      12   14                                                    0    2      4     6     8    10     12   14 <br />                                                                                  Time, days                                                                                     Time, days <br />  <br /> Fig. 3. Growth analyses WT DKO cells vitro. The cumulative growth curves normalization dilution subculture WT <br /> (A) DKO (B) cells determined weeks HMI9T (open circles), TBMFCS (closed circles) TBMdFCS (open squares). <br />  <br />  <br /> eliminate pyrimidines. Under conditions, WT cells                                                                      support growth DKO line concentrations to <br /> continue grow robustly TBMdFCS increase                                                                 1 mM. Only uracil uridine effective a <br /> in doubling time (7.6 h), DKO cells unable                                                                     marked preference uracil uridine GC50 values <br /> grow perished day 4 (Fig. 3, Table S1). Growth                                                                 0.72 &#177; 0.04 &#956;M 250 &#177; 10 &#956;M respectively (Fig. 4B). <br /> of DKO line restored supplementing TBMdFCS                                                                        Interestingly, uracil inhibit growth of <br /> with 100 &#956;M uracil uridine. In presence uracil,                                                                    T. brucei concentrations &gt; 100 &#956;M. The DKO cell line <br /> these parasites able grow rate WT                                                                     &#8764; 8-fold susceptible inhibition compared <br /> cells doubling time 7.4 h, growth                                                                      WT cells EC50 values 140 &#177; 5 &#956;M and <br /> significantly slower (doubling time 17 h) uridine.                                                                   1140 &#177; 150 &#956;M respectively. A similar effect noted <br /> Supplementation uracil uridine marginally                                                                       uridine, growth inhibition observed con- <br /> enhances growth WT cells (Table S1). A parallel                                                                       centrations 2.5 mM. <br /> study TBMFCS TBMdFCS containing 160 &#956;M thymidine <br /> confirmed thymidine effect growth WT <br />                                                                                                                              Evaluation UMPS drug target T. brucei <br /> or DKO lines (Table S1). <br />                                                                                                                              A variety inhibitors known disrupt pyrimidine <br />                                                                                                                              metabolism examined effects various <br /> Requirement pyrimidine supplementation <br />                                                                                                                              T. brucei cell lines TBMFCS. These inhibitors include <br /> To investigate pyrimidine requirement, WT                                                                      pyrazofurin, 5-fluoroorotic acid, 5-fluorouracil, 5-fluorou- <br /> and DKO trypanosomes cultured TBMdFCS supple-                                                                        ridine, 5-bromodeoxyuridine 6-azauridine. Pyrazo- <br /> mented varying concentrations pyrimidine                                                                             furin (as pyrazofurin monophosphate) potent inhibitor <br /> bases (cytosine, thymine, uracil) corresponding                                                                    OMPDC organisms including Trypano- <br /> nucleosides (cytidine, thymidine, uridine) (Fig. 4). Cyto-                                                                   soma cruzi (Hammond Gutteridge, 1983), while <br /> sine, cytidine, thymine thymidine unable                                                                         5-fluoroorotate analogue orotate requires <br />                     Relative Fluorescence Units <br />  <br />  <br />  <br />  <br />                                                                                                                Relative Fluorescence Units <br />  <br />  <br />  <br />  <br />                                                    40,000              A                                                                               40,000       B <br />  <br />  <br />  <br />                                                    20,000                                                                                              20,000 <br />  <br />  <br />  <br />  <br />                                                                0                                                                                               0 <br />                                                                    0.01    0.1    1    10   100 1,000 10,000                                                       0.01   0.1    1    10   100 1,000 10,000 <br />                                                                                  [Pyrimidine], &#181;M                                                                               [Pyrimidine], &#181;M <br />  <br /> Fig. 4. Growth WT DKO cells cultured varying concentrations uracil uridine. <br /> A. WT cells. <br /> B. DKO cells. Symbols: plus uracil (open circles) uridine (closed circles). <br />  <br />                &#169; 2013 The Authors. Molecular Microbiology published John Wiley &amp; Sons Ltd., Molecular Microbiology, 90, 443&#8211;455 <br />                                                                                                                                                   T. brucei UMP synthase drug target 447 <br />  <br /> Table 1. EC50 values inhibitors (&#956;M) different cell lines cultured TBMFCS. <br />  <br />                                                    WT                                                      SKOHYG                                                   DKO <br />  <br /> Pyrazofurin                                        0.55 &#177; 0.02                                             0.42 &#177; 0.08                                              0.42 &#177; 0.03 <br /> 5-Fluoroorotic acid                                2.27 &#177; 0.14                                             1.92 &#177; 0.21                                              &gt; 100 <br /> 5-Fluorouracil                                     11.7 &#177; 0.52                                             8.45 &#177; 0.86                                              0.64 &#177; 0.08 <br /> 5-Fluorouridine                                    &gt; 100                                                   &gt; 100                                                    &gt; 100 <br /> 5-Bromodeoxyuridine                                &gt; 100                                                   &gt; 100                                                    &gt; 100 <br /> 6-Azauridine                                       &gt; 100                                                   &gt; 100                                                    &gt; 100 <br /> Eflornithine                                       10.5 &#177; 0.30                                             7.49 &#177; 0.17                                              8.70 &#177; 0.26 <br /> Pentamidine                                        0.88 (&#215; 10&#8722;3) &#177; 0.03                                    1.17 (&#215; 10&#8722;3) &#177; 0.03                                     0.97 (&#215; 10&#8722;3) &#177; 0.03 <br />  <br /> Results means &#177; SEM triplicate measurements. <br />  <br />  <br />  <br /> metabolism UMPS produce 5-FUMP,                                                cells, DKO parasites &#8764; 18-fold sensitive. <br /> incorporated RNA sugar nucleotides (Chaudhuri                                             All cell types completely insensitive uridine <br /> et al., 1958; Santoso Thornburg, 1992). Like 5-                                                analogues, sensitivity standard drugs eflorni- <br /> fluorouracil 5-fluorouridine, 5-fluoroorotate                                       thine pentamidine unchanged. Addition of <br /> converted FdUMP, inhibiting thymidylate synthase                                             160 &#956;M thymidine medium did affect sensitivity <br /> well, disrupting DNA metabolism mammalian                                               pyrazofurin, 5-fluoroorotate 5-fluorouracil. <br /> cells (Pinedo Peters, 1988). WT T. brucei cells were <br /> found sensitive inhibitors: <br />                                                                                                    Virulence DKO parasites mice <br /> pyrazofurin, 5-fluoroorotate 5-fluorouracil (Table 1). <br /> Surprisingly, little change potency observed                                          Mammalian blood plasma contains micromolar levels of <br /> when pyrazofurin tested DKO SKOHYG                                                 pyrimidines, primarily uridine the <br /> cells. In addition, sensitivity WT cells affected                                       preferred nucleoside taken cells (Karle et al., 1981; <br /> by supplementation uridine, uracil orotate (Fig.                                           Moyer et al., 1985). However, T. brucei utilize <br /> S2). These results suggest pyrazofurin inhibit-                                        uridine efficiently, non-physiological levels this <br /> ing OMPDC T. brucei growth inhibition possibly                                           nucleoside required growth (Fig. 4). With mind, <br /> due off-target effect. In case 5-fluoroorotate,                                       essentiality pyrimidine biosynthesis virulence of <br /> DKO cells completely resistant inhibitor,                                             parasites examined animal model for <br /> consistent requirement UMPS convert                                                  infection. Groups mice inoculated WT or <br /> 5-fluoroorotate 5-FUMP. While SKO cells displayed                                             DKO parasites grown TBMFCS. The para- <br /> similar sensitivity 5-fluorouracil compared WT                                         sitaemia survival mice monitored <br />  <br />  <br />                     A                                                            B                                                           C <br />               100                                                      100                                                             100 <br />  <br />                80                                                      80                                                               80 <br />                                                          Survival, % <br /> Survival, % <br />  <br />  <br />  <br />  <br />                                                                                                                          Survival, % <br />  <br />  <br />  <br />  <br />                60                                                      60                                                               60 <br />  <br />                40                                                      40                                                               40 <br />  <br />                20                                                      20                                                               20 <br />  <br />                 0                                                        0                                                               0 <br />                     0   5   10      15   20   25    30                       0       5   10      15   20     25     30                       0     5      10      15     20      25      30 <br />                                  Time, days                                                   Time, days                                                       Time, days <br />  <br /> Fig. 5. Virulence parasites mice. Groups 5 mice infected intraperitoneally WT DKO parasites various culturing <br /> conditions. <br /> A. Virulence T. brucei cultured TBMFCS. Inoculum: 104 WT parasites (open circles) 104 DKO parasites (closed circles) <br /> B. Virulence T. brucei prolonged culture HMI9T. Inoculum: WT parasites 104 (open circles) 106 (open squares); DKO parasites <br /> 104 (closed circles) 106 (closed squares). <br /> C. Virulence DKO parasites short-term culture TBMFCS plus thymidine versus HMI9T. Inoculum: 104 WT parasites cultured HMI9T <br /> (open squares); 104 DKO parasites cultured HMI9T (open circles) TBMFCS plus thymidine (closed circles). Another group five <br /> mice infected 104 DKO parasites isolated infected mouse panel B (closed squares). Infections studies were <br /> monitored period 30 days <span id='am-76' about='obo:NCBITaxon_1369087' typeof='obo:NCBITaxon_37567 owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_85604 obo:NCBITaxon_104431 obo:NCBITaxon_33154 obo:NCBITaxon_37570 obo:NCBITaxon_41191 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_33208 obo:NCBITaxon_41196 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_95182 obo:NCBITaxon_41197 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_7088 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_7100 obo:NCBITaxon_33392 obo:NCBITaxon_50557'><span id='am-77'  ></span><span id='am-78' property="rdfs:label" content="Data" datatype="xsd:string"></span><span id='am-79' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-80' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>data</span> presented form Kaplan&#8211;Meier survival plot. <br />  <br /> &#169; 2013 The Authors. Molecular Microbiology published John Wiley &amp; Sons Ltd., Molecular Microbiology, 90, 443&#8211;455 <br />  448 H. B. Ong et al. &#9632; <br />  <br /> over period 30 days (Fig. 5A). Mice infected WT           mouse died day 12. Surprisingly, DKOM parasites <br /> parasites achieved terminal parasitaemia &gt; 108 ml&#8722;1            highly infectious behaved like WT para- <br /> on day 4, mice infected DKO parasites           sites. All animals succumbed infection days 5 <br /> remained completely free parasites 30 days.               8, waves parasitaemia observed the <br /> This result suggests UMPS essential virulence           second study noticeably absent. However, mice <br /> of T. brucei mice.                                               infected stabilate DKO line been <br />    After subculturing HMI9T 4 months,              cultured weeks remained parasite-free <br /> animal studies repeated. This eliminate            30 days regardless medium were <br /> any possible discrepancy regarding viability para-           cultured in. Collectively, findings reinforced the <br /> sites cultured richer HMI9T versus TBMFCS               results animal study UMPS essential for <br /> might affect virulence. In addition,              virulence survival T. brucei vivo. <br /> groups mice infected higher dose <br /> of T. brucei (106 cells) investigate inoculum- <br /> dependent effect infectivity. Mice infected             Pyrimidine growth requirements <br /> higher inoculum (106 parasites) WT parasites suc- <br />                                                                     To address differences virulence original DKO <br /> cumbed infection earlier, day 3 day 4 <br />                                                                     cell line subjected prolonged cultur- <br /> (104 parasites) (Fig. 5B). However, results observed <br />                                                                     ing infectious DKOM, re-examined ability of <br /> with mice infected DKO parasites unexpected. <br />                                                                     various pyrimidines support growth (Table 2). Uracil, <br /> Mice infected higher dose DKO parasites went <br />                                                                     uridine, UMP deoxyuridine supported robust growth <br /> through waves detectable, terminal, para- <br />                                                                     GC50 values micromolar range. Pseudouridine, <br /> sitaemia (i.e. &gt; 105 &lt; 108 ml&#8722;1) starting day 2 before <br />                                                                     degradation product RNA, supported growth con- <br /> succumbing infection days 7 8. Mice infected <br />                                                                     centrations 500 &#956;M, unable deter- <br /> with lower dose showed detectable parasitaemia in <br />                                                                     accurate GC50 value pyrimidine its <br /> three mice commencing 8 days inocula- <br />                                                                     limited solubility. While cells grew extent at <br /> tion. The positive mice underwent second wave <br />                                                                     cytidine concentrations 1 5 mM, GC50 <br /> of non-terminal parasitaemia reaching terminal <br />                                                                     value determined toxicity above <br /> parasitaemia days 15 16. A fourth mouse was <br />                                                                     5 mM. Total RNA yeast (1 mg ml&#8722;1) inactive. <br /> found infected day 20, reaching terminal para- <br />                                                                     Thymidine, thymine, cytosine dihydrouracil were <br /> sitaemia day 24, final mouse remained <br />                                                                     unable support growth concentrations 1 mM. <br /> parasite-free entire 30 days. Parasites these <br />                                                                     Although GC50 values similar cell <br /> mice subsequently isolated cultured HMI9T <br />                                                                     types, consistent minor difference cells <br /> medium. Analysis cells Southern blotting <br />                                                                     grown uracil pyrimidines, the <br /> revealed UMPS absent indicating infec- <br />                                                                     DKOM line unable achieve maximum <br /> tions accidental contamination by <br />                                                                     density DKO line (Fig. 6A). The exception was <br /> WT parasites (Fig. S1). Furthermore, parasites <br />                                                                     uridine (Fig. 6B). Differences maximum cell density <br /> remained auxotrophic pyrimidines; requirement <br />                                                                     observed parasites cultured in <br /> for uracil uridine supplementation suscepti- <br />                                                                     HMI9T TBMFCS doubling times identical in <br /> bility 5-fluorouracil pyrazofurin changed. <br />                                                                     media provided cells subcultured two <br />    Contrary animal study, second study <br />                                                                     days. Collectively, results suggest a <br /> suggests novo pyrimidine synthesis be <br />                                                                     subtle change pyrimidine metabolism provided <br /> essential parasite survival vivo. However, ability <br />                                                                     advantage DKOM cells survival animals <br /> of umps null mutants infect mice depend- <br />                                                                     compromised growth culture. <br /> ent overall health inoculum i.e. culture con- <br /> ditions prior infection. To definitively address this <br /> possibility, vivo study carried (Fig. 5C). <br />                                                                     Uracil uridine transport <br /> A stabilate original DKO sub- <br /> jected prolonged culture vitro used establish          The kinetics uridine uracil transport investi- <br /> cultures TBMFCS HMI9T. Groups mice             gated determine upregulation pyrimidine <br /> were inoculated 104 DKO parasites cultured           uptake contribute virulence survival (Fig. 7). <br /> medium infectivity compared mice infected             Uptake uracil linear 2 min obeys <br /> WT DKO parasites isolated mice (DKOM)                simple Michaelis Menten kinetics. Km values not <br /> second study, cultured HMI9T. Four            significantly different, Vmax DKO DKOM lines <br /> out mice infected WT parasites succumbed            (Table 2) marginally increased &#8764; 1.4 &#8764; 1.2- <br /> parasitaemia day 4 following infection,           fold respectively. In contrast, transport kinetics of <br />  <br />                &#169; 2013 The Authors. Molecular Microbiology published John Wiley &amp; Sons Ltd., Molecular Microbiology, 90, 443&#8211;455 <br />                                                                                                                                                                                       T. brucei UMP synthase drug target 449 <br />  <br /> Table 2. A comparison pyrimidine metabolism transport WT, DKO DKOM trypanosomes. <br />  <br /> Parameter                                                       Units                                     WT                                                            DKO                                 DKOM <br />  <br /> Pyrimidine GC50 <br />   Uracil                                                        &#956;M                                        N/A                                                            0.81 &#177; 0.04 (3)                     0.36 &#177; 0.03 (3) <br />   Uridine                                                       &#956;M                                        N/A                                                             190 &#177; 10 (2)                        779 &#177; 70 (2) <br />   UMP                                                           &#956;M                                        N/A                                                             295 &#177; 10 (3)                        320 &#177; 20 (3) <br />   Deoxyuridine                                                  &#956;M                                        N/A                                                             235 &#177; 10 (3)                        259 &#177; 4 (3) <br /> Transport kinetics <br />   Uracil Vmax                                                   pmol s&#8722;1 (108 cells)&#8722;1                     0.52 &#177; 0.02                                                   0.75 &#177; 0.06                         0.64 &#177; 0.04 <br />   Km                                                            &#956;M                                         0.28 &#177; 0.04                                                   0.51 &#177; 0.14                         0.36 &#177; 0.10 <br />   Uridine Vmax                                                  pmol s&#8722;1 (108 cells)&#8722;1                      101 &#177; 6                                                        96 &#177; 16                            100 &#177; 10 <br />   Km                                                            &#956;M                                        2,300 &#177; 500                                                   2,400 &#177; 1,500                       3,000 &#177; 1,100 <br /> Orotate production <br />   HMI9 medium                                                   pmol s&#8722;1 (108 cells)&#8722;1                    0                                                              5.91 &#177; 0.16 (3)                     6.75 &#177; 0.14 (3) <br />   TBMdFCS                                                       pmol s&#8722;1 (108 cells)&#8722;1                    0                                                              6.80 &#177; 0.25 (3)                     8.61 &#177; 0.29 (3) <br /> Orotate toxicity <br />   EC50                                                          &#956;M                                             153 &#177; 6 (2)                                              Non-toxica                          Non-toxica <br />  <br /> a. No growth inhibition 1 mM. <br /> Results weighted means &#177; SEM (number experiments parentheses). <br />  <br />  <br />  <br />  <br /> uridine significantly different WT,                                                                                       concentration orotate spent medium DKOM <br /> DKO DKOM trypanosomes.                                                                                                                     cells noted consistently higher compared with <br />                                                                                                                                                DKO parasites experiments. This difference <br />                                                                                                                                                prominent 96 h (at 30 &#177; 1.2 &#956;M <br /> Orotate production cells <br />                                                                                                                                                35 &#177; 1.7 &#956;M DKO DKOM respectively, n = 2, <br /> To investigate differences pyrimidine                                                                                     P = 0.07). To establish DKOM parasites were <br /> utilization DKO DKOM cells vitro, spent                                                                                     producing orotate, log phase cells (&#8764; 3 &#215; <br /> media following 72 h culture analysed HPLC.                                                                                         106 cells ml&#8722;1) cultured HMI9T harvested, washed <br /> Consistent requirement salvage pyrimidines                                                                                     resuspended fresh medium 1 &#215; 107 cells ml&#8722;1. <br /> growth, DKO cell lines took uracil WT                                                                                        Media samples collected regular intervals and <br /> parasites (Fig. 8A). There differences cytidine,                                                                                    analysed orotate production (Fig. 9A). The rate of <br /> cytosine thymidine levels spent medium                                                                                       orotate production DKO cells HMI9T linear <br /> three cell types. Uridine levels spent medium                                                                                     time 6 h (2.26 &#177; 0.07 &#956;M h&#8722;1, weighted <br /> not accurately quantified presence 1 mM                                                                                       means 3 independent experiments) slowed <br /> hypoxanthine elutes closely uridine                                                                                          reaching 19.2 &#177; 0.45 &#956;M 12 h. The initial <br /> interferes analyses.                                                                                                                  rate orotate production DKOM cells &#8764; 1.1-fold <br />    A striking observation analyses                                                                                          higher (2.39 &#177; 0.05 &#956;M h&#8722;1) achieving maximum &#8764; 1.4- <br /> presence orotic acid spent medium DKO                                                                                             fold higher 12 h (26.6 &#177; 1.31 &#956;M). This difference in <br /> and DKOM, WT, cells (Fig. 8B). After 72 h,                                                                                         orotate production cell types more <br />                                                                                                                  Relative Fluorescence Units <br />                  Relative Fluorescence Units <br />  <br />  <br />  <br />  <br />                                                            A                                                                                              B <br />                                                40,000                                                                                          40,000 <br />  <br />  <br />  <br />  <br />                                                20,000                                                                                          20,000 <br />  <br />  <br />  <br />  <br />                                                    0                                                                                               0 <br />                                                    0.001       0.01     0.1        1         10   100   1000                                       0.01       0.1   1         10     100    1000   10000 <br />                                                                               [Uracil], &#181;M                                                                              [Uridine], &#181;M <br />  <br /> Fig. 6. Growth DKO DKOM cells varying concentrations uracil uridine. <br /> A. Growth varying concentrations uracil. <br /> B. Growth varying concentrations uridine. Symbols: DKO (open circles) DKOM (closed circles). <br />  <br /> &#169; 2013 The Authors. Molecular Microbiology published John Wiley &amp; Sons Ltd., Molecular Microbiology, 90, 443&#8211;455 <br />  450 H. B. Ong et al. &#9632; <br />  <br />                                                                 0.8 <br />  <br />  <br />  <br />  <br />                                 -1 <br />  <br />  <br />  <br />  <br />                                                                                                                                       -1 <br />                                                                                                                                                                        100 <br />  <br />  <br />  <br />  <br />                                 Uptake, pmol s -1 [108 cells] <br />                                                                           A <br />  <br />  <br />  <br />  <br />                                                                                                                                       Uptake, pmol s -1 [108 cells] <br />                                                                                                                                                                                  B <br />                                                                 0.6                                                                                                     80 <br />  <br />                                                                                                                                                                         60 <br />                                                                 0.4 <br />  <br />                                                                                                                                                                         40 <br />                                                                 0.2 <br />                                                                                                                                                                         20 <br />  <br />                                                                  0                                                                                                       0 <br />                                                                       0                               2                 4         6                                          0           10,000        20,000        30,000 <br />                                                                                                           [Uracil], &#181;M                                                                      [Uridine], &#181;M <br />  <br /> Fig. 7. Uptake uracil uridine. <br /> A. Uptake 0.07 &#956;M 3H-uracil presence varying concentrations unlabelled uracil. <br /> B. Uptake 0.5 &#956;M 3H-uridine presence varying concentrations unlabelled uridine. <br /> Symbols: WT (open circles) DKOM (closed squares) DKO (open squares). <br />  <br />  <br />                                                                                                                                                                       apparent cells incubated pyrimidine-free <br />                     3    A                                                                            15        B                                                     medium (TBMdFCS, Fig. 9B; Table 2). While rate of <br />                                                                                                                                                                       orotate production DKO cells remained unchanged <br /> Concentration, &#181;M <br />  <br />  <br />  <br />  <br />                                                                                   Concentration, &#181;M <br />  <br />  <br />  <br />  <br />                                                                                                                                                                       (2.44 &#177; 0.10 &#956;M h&#8722;1), rate DKOM cells <br />                     2                                                                                 10                                                              increased &#8764; 1.3-fold (3.12 &#177; 0.10 &#956;M h&#8722;1, n = 3, <br />                                                                                                                                                                       P = 0.001). The peak amounts orotate 12 h were <br />                                                                                                                                                                       determined 19.6 &#177; 0.12 &#956;M 29.9 &#177; 0.64 &#956;M <br />                                                                                                                                                                       respectively. These results suggest DKOM cells were <br />                     1                                                                                     5 <br />                                                                                                                                                                       able produce orotate DKO cells and <br />                                                                                                                                                                       able increase rate orotate pro- <br />                                                                                                                                                                       duction pyrimidine-free environment. Such character- <br />                     0                                                                                     0                                                           istics confer DKOM cells advantage <br />                           WT DKO DKOM                                                                          WT DKO DKOM <br />                                                                                                                                                                       DKO cells relation infection survival in <br />                         Uracil utilization                                                                    Orotate production <br />                                                                                                                                                                       mouse host. <br /> Fig. 8. Utilization uracil production orotate. Cells were <br /> cultured HMI9T initial seeding density 1 &#215; 103 cells ml&#8722;1, <br /> with medium harvested 72 h analysed HPLC. A B                                                                                                        Discussion <br /> show uracil utilized orotate produced WT <br /> (closed bars), DKO (open bars) DKOM (gray bars) cells. The                                                                                                        The results current study demonstrate UMPS <br /> respective cell densities stage 7.2 &#215; 106 cells ml&#8722;1 (WT) <br /> and 3.2 &#215; 106 cells ml&#8722;1 (DKO DKOM). The initial concentration <br />                                                                                                                                                                       essential growth bloodstream T. brucei in <br /> of uracil medium 4.43 &#177; 0.26 &#956;M.                                                                                                                           pyrimidine-depleted medium. Growth supported by <br />  <br />  <br />                                                                 30                                                                                                      30 <br />  <br />                                                                           A                                                                                                      B <br />                                                                                                                                                        Orotate, &#181;M <br />                                Orotate, &#181;M <br />  <br />  <br />  <br />  <br />                                                                 20                                                                                                      20 <br />  <br />  <br />  <br />  <br />                                                                 10                                                                                                      10 <br />  <br />  <br />  <br />  <br />                                                                  0                                                                                                       0 <br />                                                                       0       2                       4         6    8      10   12                                          0       2     4       6     8      10    12 <br />                                                                                                               Time, h                                                                             Time, h <br />  <br /> Fig. 9. Overproduction orotate umps null mutants. Log-phase cells cultured HMI9T harvested, washed resuspended in <br /> fresh medium 1 &#215; 107 cells ml&#8722;1. Medium harvested various specified time intervals analysed HPLC. The production of <br /> orotate time DKO (open squares) DKOM (closed squares) cells measured HMI9T (A) TBMdFCS (B). <br />  <br />                              &#169; 2013 The Authors. Molecular Microbiology published John Wiley &amp; Sons Ltd., Molecular Microbiology, 90, 443&#8211;455 <br />                                                                                                  T. brucei UMP synthase drug target 451 <br />  <br /> uracil, uridine, deoxyuridine UMP robustly          potently inhibits OMPDC activity (Hammond and <br /> pseudouridine cytidine (UMP presumed                   Gutteridge, 1983). However, identical potency of <br /> metabolized uridine extracellular nucleotidases           pyrazofurin various cell lines tested indi- <br /> phosphatases prior uptake). Other pyrimidines           cates OMPDC primary target T. brucei <br /> dihydrouracil, cytidine, cytosine, thymine thymidine did        anti-trypanosomal properties other <br /> not support growth. These pyrimidine requirements              &#8216;off-target&#8217; effects. This deserves investigation. <br /> bloodstream T. brucei entirely consistent recent             So, biochemical changes account the <br /> transport studies report uracil uridine          lack infectivity DKO parasites mice? The GC50 <br /> taken bloodstream forms single transporter,            transport Km values obtained vitro suggest that <br /> designated U3, distinct insect stage          uracil preferred uridine vivo. Radiolabel- <br /> transporters U1, U2 C1 (Ali et al., 2013a). Our uracil         ling studies mice indicate [5-3H]-uracil rapidly <br /> and uridine transport kinetic parameters good               catabolized trace salvaged nucleo- <br /> agreement published values.                               tides (Moyer et al., 1985). Unfortunately, reliable informa- <br />    Loss UMPS activity DKO results             tion plasma concentration uracil mice is <br /> biochemical differences compared WT trypano-                  lacking, &#8764; 0.1 &#956;M humans (Coudore et al., 2012). <br /> somes. First, uracil transport capacity DKO cells               If concentration uracil mice equivalent to <br /> increases 1.4-fold associated fivefold               humans, case uridine (Moyer et al., 1981), <br /> increase utilization uracil medium meet          uracil level (GC50 0.81 &#956;M) insuf- <br /> its nutritional requirements. Based uracil depletion            ficient support growth. Based transport data the <br /> from medium, rate uracil utilization             DKO cell uracil mouse plasma at <br /> estimated 0.96 pmol s&#8722;1 (108 cells)&#8722;1, consistent       0.12 pmol s&#8722;1 (108 cells)&#8722;1, considerably the <br /> the transport Vmax uracil 0.75 pmol s&#8722;1 (108 cells)&#8722;1.      estimated growth, i.e. 0.96 pmol s&#8722;1 <br /> Second, biosynthetic intermediate, orotate,                 (108 cells)&#8722;1. The serum concentration uridine mouse <br /> secreted medium large amounts DKO,              plasma range 2 5 &#956;M, uridine (GC50 <br /> not WT cells. Notably, flux              190 &#956;M) low support growth. At the <br /> pathway orotate [5.9 pmol s&#8722;1 (108 cells)&#8722;1] exceeds        upper plasma concentration DKO cell up <br /> amount uracil estimated growth HMI9T sixfold.         uridine 0.2 pmol s&#8722;1 (108 cells)&#8722;1, slightly higher than <br /> In addition, extracellular orotate toxic WT,         uracil. So despite fact Km Vmax these <br /> DKO cells (Table 2). This suggests toxicity         pyrimidines differ orders magnitude, rates of <br /> conversion excess orotate UMP pyrimi-              uptake physiological conditions predicted be <br /> dine nucleotides. It indicates regulation          similar. However, important note transport of <br /> novo synthesis occur earlier pathway. The              uridine physiological levels present plasma will <br /> regulatory mechanism unknown trypanosomatids,                proportional uridine concentration [S] &lt; &lt; Km. <br /> but, mammalian cells, occurs feedback inhibi-          Based current information, contribution deoxyu- <br /> tion UTP protein phosphorylation            ridine, UMP pyrimidines growth impossible <br /> multifunctional enzyme pathway, CAD (Evans              quantify. However, concluded total <br /> Guy, 2004). Third, complete loss inhibitory activity        rate salvage uridine plus uracil [0.32 pmol s&#8722;1 (108 <br /> of 5-fluororotate DKO trypanosomes indicates               cells)&#8722;1] estimated <br /> this molecule converted 5-FUMP UMPS              required normal growth. <br /> to exert toxicity. Further conversion incorporation           So, explanations surprising discov- <br /> into UDP-sugars RNA, deoxyuridine                 ery DKO trypanosomes regained infectivity mice, <br /> nucleotides DNA, suggests mode action                    having maintained long-term culture? We have <br /> does involve inhibition thymidylate synthase (Ali           carried extensive investigations try answer this <br /> et al., 2013a). This supported fact dhfr-ts         question. The genes enzymes involved pyrimidine <br /> null mutants equally sensitive 5-fluororotate               salvage (cytidine deaminase, thymidine kinase, uracil <br /> (Sienkiewicz et al., 2008) and, reported here, thymi-           phosphoribosyltransferase uridine phosphorylase) <br /> dine effect growth sensitivity fluoropyrimi-          sequenced, identical WT, DKO or <br /> dines. The hypersensitivity DKO cells 5-fluorouracil         DKOM parasites. Upregulation pyrimidine transport was <br /> can explained increased transport salvage                noted umps null mutants compared WT, but <br /> activity exogenous uracil fluorinated analogue.         DKOM DKO, unlikely account <br /> Finally, pyrazofurin studied potent inhibitor        difference virulence. The significant finding <br /> of OMPDC mammalian cells (as monophosphate)                 increased production orotate, particularly a <br /> and undergone clinical trials anticancer agent.              pyrimidine-poor environment, revertant (DKOM) cell <br /> In crude extracts T. cruzi supplemented ATP                line. By doing so, trypanosomes possibly hijack host <br />  <br /> &#169; 2013 The Authors. Molecular Microbiology published John Wiley &amp; Sons Ltd., Molecular Microbiology, 90, 443&#8211;455 <br />  452 H. B. Ong et al. &#9632; <br />  <br /> metabolism convert excess orotate uridine          vate. TBM supplemented bovine FCS or <br /> pyrimidine nucleotides. Support hypothesis comes           dialysed bovine FCS (both PAA laboratories) other <br /> from fact administration orotate rats results     pyrimidines detailed text. Cell densities seeding <br />                                                                     cultures determined using CASY TT cell counter <br /> a small (twofold) sustained increase plasma uridine <br />                                                                     (Sch&#228;rfe). <br /> and cytidine levels (Gasser et al., 1981; Rosenfeldt et al., <br /> 1998). As noted above, transport uridine increases <br /> linearly changes extracellular concentration         Generation knockout constructs <br /> the physiological range, doubling plasma uridine             The PCR primers used generate constructs genetic <br /> level double rate uptake. Whether small,           manipulation designed using T. brucei UMPS <br /> but statistically significant increase orotate production        sequence GeneDB (Tb927.5.3810) template (Table <br /> between DKOM DKO cells sufficient account             S2). The accuracy assembled constructs verified by <br /> the differences virulence open debate,           sequencing. Replacement cassettes generated by <br /> clear foregoing discussion subtle differences         amplifying region DNA encompassing 5&#8242;-untranslated <br />                                                                     region (UTR), open reading frame 3&#8242;-UTR UMPS from <br /> in pyrimidine levels tip balance death <br />                                                                     genomic DNA primers 5&#8242;-UTR-NotI_s 3&#8242;-UTR- <br /> or survival parasite mouse.                           NotI_as, using Pfu polymerase. This sequence then <br />    During review process manuscript, similar          used template amplification individual <br /> knockout study published largely agrees              regions used assembly replacement cassettes con- <br /> our findings (Ali et al., 2013b). These authors          taining selectable drug resistance genes puromycin <br /> their UMPS-deficient T. brucei infectious            N-acetyl transferase (PAC) hygromycin phosphotrans- <br /> animal model. Although model proposing upregula-              ferase (HYG), exactly previously described (Martin and <br />                                                                     Smith, 2005). <br /> tion uracil transport compensatory mechanism to <br /> retain virulence conceivable, noteworthy our <br /> DKOM cells marginally decreased uracil transport             Generation T. brucei transgenic mutants <br /> compared DKO parasites. More importantly,              Knockout constructs prepared using QIAprep Miniprep <br /> authors employed H. simplex virus thymidine kinase                  Plasmid Kit (Qiagen). <span id='am-81' about='obo:NCBITaxon_36549' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_28384'><span id='am-82' property="rdfs:label" content="plasmids" datatype="xsd:string"></span><span id='am-83' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-84' property="oboInOwl:hasDbXref" content="GC_ID:11" datatype="xsd:string"></span><span id='am-85' property="oboInOwl:hasAlternativeId" content="NCBITaxon:2435" datatype="xsd:string"></span>Plasmids</span> linearized using NotI, <br /> (HSVTK) replace UMPS gene. This enzyme                   precipitated ethanol resuspended sterile water <br /> broad substrate specificity deoxynucleosides,             (1 &#956;g ml&#8722;1). Wild-type trypanosomes cultured HMI9T were <br /> including deoxyuridine (Balzarini et al., 2002),              electroporated using programme X-001 Nucleofector II <br /> could confounding effect pyrimidine metabo-               electroporator (Amaxa, Cologne, Germany) (Burkard et al., <br />                                                                     2007) following addition 5 &#956;g linearized DNA and <br /> lism T. brucei. In addition, deletion second allele <br />                                                                     reagents Human T cell Nucleofector kit manu- <br /> via loss heterozygosity involved prolonged passage            facturers&#8217; instructions. Parasites cloned limiting dilu- <br /> 5-fluoroorotate similar compensatory changes                 tion following transfection. To generate double <br /> pyrimidine metabolism reported             knockout (DKO) UMPS, allele replaced with <br /> occurred. Notwithstanding criticisms, studies            HYG. A single knockout cell-line (SKOHYG) selected by <br /> agree UMPS suitable drug target                culturing cells continuous presence hygromycin <br /> African trypanosome, case potential           (4 &#956;g ml&#8722;1). Once established, second UMPS allele in <br />                                                                     SKOHYG cells replaced PAC gene. The resulting <br /> metabolic changes leading restoration virulence. <br />                                                                     DKO cell line selected culturing cells continuous <br />                                                                     presence hygromycin puromycin (0.1 &#956;g ml&#8722;1). <br /> Experimental procedures <br />                                                                     Southern blot analysis <br /> Organisms reagents <br />                                                                     The 5&#8242;-UTR T. brucei UMPS amplified PCR (using <br /> Pyrazofurin purchased Berry &amp; Associates Inc. <br />                                                                     primers previously described generating knockout <br /> 3 <br />   H-uracil (36 Ci mmol&#8722;1) 3H-uridine (20 Ci mmol&#8722;1) were <br />                                                                     constructs) PCR DIG Probe Synthesis Kit <br /> purchased Perkin Elmer. Pseudouridine purchased <br />                                                                     (Roche). The resulting digoxigenin-labelled product used <br /> from Carbosynth. All pyrimidines purchased Sigma <br />                                                                     probe. Southern analysis carried exactly as <br /> Aldrich. Other chemicals reagents used study <br />                                                                     previously described (Wyllie et al., 2009) using samples of <br /> were highest grade purity available. Trypanosoma <br />                                                                     genomic DNA (5 &#956;g) digested restriction endonucle- <br /> brucei bloodstream-form &#8216;single marker&#8217; S427 (T7RPOL <br />                                                                     ase SacI. <br /> TETR NEO) cultured 37&#176;C HMI9T (Greig et al., <br /> 2009), supplemented 2.5 &#956;g ml&#8722;1 G418 (Geneticin, <br /> Invitrogen). Trypanosome base media (TBM) derived                Concentration pyrimidines required half <br /> from HMI11 (Hirumi Hirumi, 1989) consists                maximal growth <br /> Iscove&#8217;s modified Dulbecco&#8217;s MEM supplemented with <br /> 0.05 mM bathocuproine, 1.5 mM cysteine, 1 mM hypoxan-               The ability different pyrimidines support growth of <br /> thine, 0.2 mM 2-mercaptoethanol 1 mM sodium pyru-               DKO lines investigated pyrimidine-free TBM <br />  <br />                &#169; 2013 The Authors. Molecular Microbiology published John Wiley &amp; Sons Ltd., Molecular Microbiology, 90, 443&#8211;455 <br />                                                                                                      T. brucei UMP synthase drug target 453 <br />  <br /> supplemented 10% dialysed fetal calf serum (TBMdFCS).          Microfuge tubes flash frozen liquid nitrogen the <br /> The concentration various pyrimidines required support        tubes containing cell pellets snipped <br /> growth determined 96-well microtitre plates final       directly scintillation vials. Pellets solubilized in <br /> culture volume 200 &#956;l initial parasite           1 M NaOH (150 &#956;l) overnight mixed scintillation fluid <br /> seeding density 2.5 &#215; 103 cells ml&#8722;1. Stock solutions cyti-   (2 ml) radioactivity determined using liquid scin- <br /> dine, thymidine, uridine, pseudouridine, deoxyuridine           tillation counter. Uptake 3H-uridine (0.5 &#956;M) pres- <br /> UMP prepared water, cytosine, thymine, uracil,          ence varying concentrations unlabelled uridine (195 to <br /> dihydrouracil <span id='am-70' about='obo:NCBITaxon_430997' typeof='obo:NCBITaxon_33154 owl:Thing obo:NCBITaxon_451864 obo:NCBITaxon_147538 obo:NCBITaxon_1 obo:NCBITaxon_171187 obo:NCBITaxon_4890 obo:NCBITaxon_4751 obo:NCBITaxon_131567 obo:NCBITaxon_716545 obo:NCBITaxon_2759'><span id='am-71' property="rdfs:label" content="Torula" datatype="xsd:string"></span><span id='am-72'  ></span><span id='am-73' property="oboInOwl:hasRelatedSynonym" content="Torula Pers." datatype="xsd:string"></span><span id='am-74' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-75' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>torula</span> yeast total RNA (Sigma Aldrich)       25 000 &#956;M) similarly determined, transport termi- <br /> dissolved 1 mM NaOH. Appropriate amounts solvent              nated time intervals (60, 120, 300, 450 600 s). <br /> were included control wells. Cultures incubated for <br /> 72 h cell density determined using resazurin- <br /> based assay (Raz et al., 1997; Jones et al., 2010). The con-        Analysis purines pyrimidines media serum <br /> centration pyrimidine required support 50% <br />                                                                     Purines pyrimidines samples analysed HPLC <br /> maximum cell growth (GC50) determined plotting cell <br />                                                                     previously described (Tavazzi et al., 2005). Analytes were <br /> density versus pyrimidine concentration analysed by <br />                                                                     separated ODS-2 Hypersil column (Thermo) using a <br /> 4-parameter non-linear regression using GraFit. <br />                                                                     Dionex UltiMate 3000 coupled Dionex UltiMate <br />                                                                     3000 variable UV detector. Samples mobile phase were <br />                                                                     prepared previously described (Tavazzi et al., 2005), with <br /> EC50 determination inhibitors of <br />                                                                     exception tetrabutylammonium hydroxide the <br /> pyrimidine metabolism                                               mobile phases replaced tetrabutylammonium <span id='am-86' about='obo:NCBITaxon_128483' typeof='owl:Thing obo:NCBITaxon_33208 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_33154 obo:NCBITaxon_216303 obo:NCBITaxon_37796 obo:NCBITaxon_1206795 obo:NCBITaxon_69555 obo:NCBITaxon_6447 obo:NCBITaxon_33317 obo:NCBITaxon_6448 obo:NCBITaxon_2759 obo:NCBITaxon_6479 obo:NCBITaxon_216293 obo:NCBITaxon_6072'><span id='am-87' property="rdfs:label" content="Phos" datatype="xsd:string"></span><span id='am-88' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-89'  ></span><span id='am-90' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>phos</span>- <br />                                                                     phate (Sigma). <br /> EC50 values inhibitors determined using parasites <br /> cultured TBM plus 10% FCS (TBMFCS), without <br /> thymidine. The concentration inhibitors inhibit 50%           Measurement orotic acid production medium <br /> growth determined 96-well microtitre plates final <br /> culture volume 200 &#956;l initial parasite           Log-phase cells (3 &#215; 106 cells ml&#8722;1) cultured HMI9T were <br /> seeding density 2.5 &#215; 103 cells ml&#8722;1. All wells, including       harvested centrifugation (800 g, 10 min, 4&#176;C), washed <br /> controls, contained 0.5% DMSO. EC50 values deter-              fresh HMI9T TBMdFCS resuspended at <br /> mined described above.                                           1 &#215; 107 cells ml&#8722;1). Cultures incubated 37&#176;C 5% <br />                                                                     CO2. At time intervals 1, 2, 4, 6, 8 12 h, aliquots of <br />                                                                     cultures (500 &#956;l) removed medium separated from <br /> In vivo studies                                                     cells centrifugation (800 g, 10 min, 4&#176;C), treated and <br />                                                                     orotate levels measured HPLC. Orotate production over <br /> All animal experiments subject local ethical review         time analysed linear regression Grafit. Statistical <br /> and performed Animals (Scientific Procedures) Act         analyses carried using Student&#8217;s t-test two <br /> 1986 accordance European Communities Council            samples equal variance. P &lt; 0.05 considered statistically <br /> Directive (86/609/EEC). All lines parasites cultured        significant. <br /> and routinely passaged HMI9T TBMFCS plus thymidine. <br /> To avoid G418 toxicity mice, trypanosomes cultured <br /> in absence G418 4&#8211;12 h prior inoculation.             Acknowledgements <br /> Groups mice injected intraperitoneally a <br /> specified number parasites, infections parasitae-       We thank members Drug Discovery Unit biology team <br /> mia monitored period 30 days previously                initial screening data pyrazofurin Claire Paxton for <br /> described (Sienkiewicz et al., 2008). Animals reaching            assistance preparation gene knockout con- <br /> lethal parasitaemia (&gt; 108 ml&#8722;1) humanely killed           structs. This work funded Wellcome Trust (079838 <br /> recorded having died day.                                801938). <br />  <br />  <br /> Pyrimidine transport                                                References <br /> Transport uracil uridine carried previously      Ahmad, S.I., Kirk, S.H., Eisenstark, A. (1998) Thymine <br /> described (Wallace et al., 2002) modifications.              metabolism thymineless death prokaryotes and <br /> T. brucei cells cultured HMI9T harvested centrifu-          eukaryotes. Annu Rev Microbiol 52: 591&#8211;625. <br /> gation (800 g, 10 min, 4&#176;C), washed resuspended                 Ali, J.A., Creek, D.J., Burgess, K., Allison, H.C., Field, M.C., <br /> (1 &#215; 108 cells ml&#8722;1) transport buffer (Ali et al., 2013b).          Maser, P., De Koning, H.P. (2013a) Pyrimidine salvage <br /> Transport assays initiated addition 100 &#956;l cells        Trypanosoma brucei bloodstream forms trypano- <br /> to 100 &#956;l pyrimidine microfuge tubes room tempera-             cidal action halogenated pyrimidines. Mol Pharmacol 83: <br /> ture. Uptake 3H-uracil (0.07 &#956;M) determined              439&#8211;453. <br /> presence varying concentrations unlabelled uracil (0.08       Ali, J.A., Tagoe, D.N., Munday, J.C., Donachie, A., Morrison, <br /> to 5 &#956;M). At specific time intervals (30, 60, 90, 120 150 s)       L.J., De Koning, H.P. (2013b) Pyrimidine biosynthesis <br /> transport terminated centrifugation (16 000 g, 1 min)           essential function Trypanosoma brucei blood- <br /> through silicone oil (200 &#956;l, Medford Silicones Inc.).                 stream forms. PLoS ONE 8: E58034. <br />  <br /> &#169; 2013 The Authors. Molecular Microbiology published John Wiley &amp; Sons Ltd., Molecular Microbiology, 90, 443&#8211;455 <br />  454 H. B. Ong et al. &#9632; <br />  <br /> Alsford, S., Turner, D.J., Obado, S.O., Sanchez-Flores, A.,           Trypanosoma brucei blood stream forms medium con- <br />   Glover, L., Berriman, M., et al. (2011) High-throughput phe-        taining low concentration serum protein feeder <br />   notyping using parallel sequencing Rna interference              cell layers. J Parasitol 75: 985&#8211;989. <br />   targets African trypanosome. Genome Res 21: 915&#8211;           Jones, D.C., Ariza, A., Chow, W.H., Oza, S.L., Fairlamb, <br />   924.                                                                A.H. (2010) Comparative structural, kinetic inhibitor <br /> Arakaki, T.L., Buckner, F.S., Gillespie, J.R., Malmquist, N.A.,       studies Trypanosoma brucei trypanothione reductase <br />   Phillips, M.A., Kalyuzhniy, O., et al. (2008) Characteriza-         T. cruzi. Mol Biochem Parasitol 169: 12&#8211;19. <br />   tion Trypanosoma brucei dihydroorotate dehydrogenase           Karle, J.M., Anderson, L.W., Dietrick, D.D., Cysyk, R.L. <br />   possible drug target; structural, kinetic Rnai             (1981) Effect inhibitors novo pyrimidine biosyn- <br />   studies. Mol Microbiol 68: 37&#8211;50.                                   thetic pathway serum uridine levels mice. <span id='am-44' about='obo:NCBITaxon_6754' typeof='owl:Thing obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_72041 obo:NCBITaxon_33154 obo:NCBITaxon_6681 obo:NCBITaxon_6682 obo:NCBITaxon_6683 obo:NCBITaxon_29964 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_33208 obo:NCBITaxon_116706 obo:NCBITaxon_116704 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_6656 obo:NCBITaxon_6692 obo:NCBITaxon_1206794 obo:NCBITaxon_6657 obo:NCBITaxon_6753 obo:NCBITaxon_88770 obo:NCBITaxon_6752'><span id='am-45' property="rdfs:label" content="Cancer" datatype="xsd:string"></span><span id='am-46'  ></span><span id='am-47' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-48' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Cancer</span> Res <br /> Balzarini, J., Liekens, S., Esnouf, R., De Clercq, E.             41: 4952&#8211;4955. <br />   (2002) The A167Y mutation converts Herpes simplex             Martin, K., Smith, T.K. (2005) The myo-inositol-1- <br />   virus Type 1 thymidine kinase guanosine analogue             phosphate synthase gene essential Trypanosoma <br />   kinase. Biochemistry 41: 6517&#8211;6524.                                 brucei. Biochem Soc Trans 33: 983&#8211;985. <br /> Burkard, G., Fragoso, C.M., Roditi, I. (2007) Highly            Moyer, J.D., Oliver, J.T., Handschumacher, R.E. (1981) <br />   efficient stable transformation bloodstream forms             Salvage circulating pyrimidine nucleosides rat. <br />   Trypanosoma brucei. Mol Biochem Parasitol 153: 220&#8211;                 Cancer Res 41: 3010&#8211;3017. <br />   223.                                                              Moyer, J.D., Malinowski, N., Ayers, O. (1985) Salvage of <br /> Cadman, E.C., Dix, D.E., Handschumacher, R.E. (1978)              circulating pyrimidine nucleosides tissues mouse. <br />   Clinical, biological, biochemical effects pyrazofurin.       J Biol Chem 260: 2812&#8211;2818. <br />   Cancer Res 38: 682&#8211;688.                                           Pinedo, H.M., Peters, G.F.J. (1988) Fluorouracil &#8211; <br /> Chaudhuri, N.K., Montag, B.J., Heidelberger, C. (1958)            biochemistry pharmacology. J Clin Oncol 6: 1653&#8211; <br />   Studies fluorinated pyrimidines. iii. metabolism          1664. <br />   5-fluorouracil-2-C14 5-fluoroorotic-2-C14 acid vivo.       Raz, B., Iten, M., Grether-Buhler, Y., Kaminsky, R., Brun, <br />   Cancer Res 18: 318&#8211;328.                                             R. (1997) The Alamar Blue&#174; Assay determine drug <br /> Coudore, F., Roche, D., Lefeuvre, S., Faussot, D., Billaud,           sensitivity African trypanosomes (T. b. Rhodesiense and <br />   E.M., Loriot, M.A., Beaune, P. (2012) Validation          T. b. Gambiense) vitro. Acta Trop 68: 139&#8211;147. <br />   ultra-high performance liquid chromatography tandem               Rosenfeldt, F.L., Richards, S.M., Lin, Z., Pepe, S., and <br />   mass spectrometric method quantifying uracil 5,6-           Conyers, R.A.J. (1998) Mechanism cardioprotective <br />   dihydrouracil human plasma. J Chromatogr Sci 50: 877&#8211;            effect orotic acid. Cardiovasc Drugs Ther 12: 159&#8211;170. <br />   884.                                                              Santoso, D., Thornburg, R.W. (1992) Isolation and <br /> Evans, D.R., Guy, H.I. (2004) Mammalian pyrimidine                characterization UMP synthase mutants haploid <br />   biosynthesis: fresh insights ancient pathway. J Biol        cell-suspensions <span id='am-6' about='obo:NCBITaxon_4097' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_1 obo:NCBITaxon_4070 obo:NCBITaxon_131567 obo:NCBITaxon_424562 obo:NCBITaxon_3398 obo:NCBITaxon_4085 obo:NCBITaxon_4069 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_91888 obo:NCBITaxon_91827 obo:NCBITaxon_131221 obo:NCBITaxon_71240 obo:NCBITaxon_58024 obo:NCBITaxon_424554 obo:NCBITaxon_1437201 obo:NCBITaxon_58023 obo:NCBITaxon_2759 obo:NCBITaxon_35493 obo:NCBITaxon_71274 obo:NCBITaxon_3193'><span id='am-7' property="oboInOwl:hasExactSynonym" content="common tobacco" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:hasRelatedSynonym" content="Nicotania tabacum" datatype="xsd:string"></span><span id='am-9' property="oboInOwl:hasExactSynonym" content="American tobacco" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:hasRelatedSynonym" content="Nicotiana tabacum var. Samsun" datatype="xsd:string"></span><span id='am-11' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-12' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-13'  ></span><span id='am-14' property="oboInOwl:hasExactSynonym" content="tobacco" datatype="xsd:string"></span><span id='am-15' property="rdfs:label" content="Nicotiana tabacum" datatype="xsd:string"></span>Nicotiana tabacum</span>. Plant Physiol 99: <br />   Chem 279: 33035&#8211;33038.                                              1216&#8211;1225. <br /> Fairlamb, A.H. (2003) Chemotherapy human African trypa-          Scahill, M.D., Pastar, I., Cross, G.A.M. (2008) Cre <br />   nosomiasis: current future prospects. Trends Parasitol          recombinase-based positive-negative selection systems <br />   19: 488&#8211;494.                                                        genetic manipulation Trypanosoma brucei. Mol <br /> Gasser, T., Moyer, J.D., Handschumacher, R.E. (1981)              Biochem Parasitol 157: 73&#8211;82. <br />   Novel single-pass exchange circulating uridine rat-         Shaffer, P.M., Hsu, C.A., Abbott, M.T. (1975) Metabolism <br />   liver. Science 213: 777&#8211;778.                                        pyrimidine deoxyribonucleosides <span id='am-26' about='obo:NCBITaxon_5141' typeof='obo:NCBITaxon_222544 owl:Thing obo:NCBITaxon_5139 obo:NCBITaxon_1 obo:NCBITaxon_5148 obo:NCBITaxon_131567 obo:NCBITaxon_4751 obo:NCBITaxon_147550 obo:NCBITaxon_715989 obo:NCBITaxon_33154 obo:NCBITaxon_451864 obo:NCBITaxon_147538 obo:NCBITaxon_4890 obo:NCBITaxon_716546 obo:NCBITaxon_716545 obo:NCBITaxon_2759 obo:NCBITaxon_5140'><span id='am-27' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-28' property="oboInOwl:hasRelatedSynonym" content="Chrysonilia crassa" datatype="xsd:string"></span><span id='am-29' property="rdfs:label" content="Neurospora crassa" datatype="xsd:string"></span><span id='am-30' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-31'  ></span>Neurospora crassa</span>. <br /> Greig, N., Wyllie, S., Patterson, S., Fairlamb, A.H. (2009)       J Bacteriol 121: 648&#8211;655. <br />   A comparative study methylglyoxal metabolism trypa-         Sienkiewicz, N., Jaroslawski, S., Wyllie, S., Fairlamb, <br />   nosomatids. FEBS J 276: 376&#8211;386.                                    A.H. (2008) Chemical genetic validation dihydro- <br /> Gudin, S., Quashie, N.B., Candlish, D., Al-Salabi, M.I., Jarvis,      folate reductase-thymidylate synthase drug target in <br />   S.M., Ranford-Cartwright, L.C., De Koning, H.P. (2006)          African trypanosomes. Mol Microbiol 69: 520&#8211;533. <br />   Trypanosoma brucei: survey pyrimidine transport              Stuart, K.D., Brun, R., Croft, S.L., Fairlamb, A.H., Gurtler, <br />   activities. Exp Parasitol 114: 118&#8211;125.             <br /> </body></html>